ArticleDiabetology & metabolic syndrome2025

Recent advances in understanding the mechanisms by which sodium-glucose co-transporter type 2 inhibitors protect podocytes in diabetic nephropathy.

Xinqi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.